drugset / Trial / NCT02493738

A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers

NCT02493738

Phase 1 Completed 24 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-label

Summary

Study Objectives: * To evaluate the pharmacokinetics (PK) of orally administered Lozanoc under fasted and fed condition in healthy male subjects * To compare the pharmacokinetics (PK) of orally administered Lozanoc and Sporanox under fed condition in healthy male subjects * To evaluate the safety and tolerability of single oral dose of Lozanoc and Sporanox in Korean healthy male subjects

Timeline

Start
2015-07
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Itraconazole Small molecule 100 mg Oral
Subject Lozanoc Unknown 50 mg Oral